SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase

enadenotucirev (ColoAd1) - PsiOxus

Opdivo (nivolumab) - Ono Pharma, BMS

https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/211#presentation-abstract-25181061348031

M. Fakih 1; D. Wang 2; W. Harb 3; L. Rosen 4; D. Mahadevan 5; J. Berlin 6; P. Basciano 7; R. Brown 8; O. Arogundade 8; C. Cox 8; G. Di Genova 8; D. Krige 8; H. Mcelwaine-Johnn 8

Sep 11, 2019